Lent, Netherlands

Sander Sebastiaan Van Berkel

This inventor holds 18 USPTO granted patents and 22 published patent applications and 8 EPO patents, primarily in Bioconjugate Chemistry. Top assignee: Synaffix B.v.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sander Sebastiaan Van Berkel. Retrieved from https://idiyas.com/inventor/sander-sebastiaan-van-berkel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • HR Lent, NL (2022)
  • Lent, NL (2017 - 2024)
  • Wijchen, NL (2020 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibody-Conjugates
Bioconjugates
Glycoprotein Modification
Sulfamide Linkers
PTK7 Targeting
Trop-2 Targeting
CD30 Tumours
HER2 Tumours
Enzymes
Glycosyltransferase
Therapeutic Index
Carcinoembryonic Antigen
18 patents (USPTO):Explore Patents

Title: Sander Sebastiaan Van Berkel: An Innovative Mind in Glycochemistry

Introduction

Sander Sebastiaan Van Berkel, an accomplished inventor based in Lent, Netherlands, has made significant contributions to the field of glycochemistry. With a portfolio of 15 patents, he stands out as a leading figure in the development of methods and processes that advance our understanding and manipulation of glycoproteins.

Latest Patents

One of his most recent inventions is the "Synthesis of 6-azido-6-deoxy-2-N-acetyl-hexosamine-nucleoside diphosphate." This invention details highly efficient and high-yielding methods for synthesizing 6-azido-6-deoxy-2-N-acetyl-monosaccharide-nucleoside diphosphate, specifically targeting complex molecules like 6-azido-6-deoxy-2-N-acetyl-D-galactosamine-nucleoside diphosphate and 6-azido-6-deoxy-2-N-acetyl-D-glucosamine-nucleoside diphosphate.

Another notable patent is the "Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase." This invention outlines a process for the enzymatic modification of glycoproteins by utilizing non-natural sugar-derivative nucleotides and glycosyltransferases. His work on this subject creates opportunities for new bioconjugates and innovative glycoproteins, showcasing his expertise in the field.

Career Highlights

Sander is currently associated with Synaffix B.V., where he applies his vast knowledge of biochemistry and molecular biology to drive research and innovation. His contributions have led to advancements in the synthesis and modification of crucial biomolecules, reflecting his commitment to pushing the boundaries of scientific research.

Collaborations

Throughout his career, Sander has collaborated with notable colleagues, including Floris Louis Van Delft and Maria Antonia Wijdeven. Their teamwork and shared expertise significantly enhance the impact of their research in the field of glycochemistry.

Conclusion

In conclusion, Sander Sebastiaan Van Berkel exemplifies the spirit of innovation in the field of glycochemistry. His impressive array of patents and collaborations underscores his pivotal role in advancing our understanding of glycoproteins and their modifications. Through his continued efforts at Synaffix B.V., Sander is set to make even further contributions to the scientific community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…